share_log

Earnings Call Summary | Molina Healthcare(MOH.US) Q1 2024 Earnings Conference

Earnings Call Summary | Molina Healthcare(MOH.US) Q1 2024 Earnings Conference

業績電話會議摘要 | Molina Healthcare (MOH.US) 2024 年第一季度業績會議
富途資訊 ·  04/26 06:45  · 電話會議

The following is a summary of the Molina Healthcare, Inc. (MOH) Q1 2024 Earnings Call Transcript:

以下是莫利納醫療保健公司(MOH)2024年第一季度業績電話會議記錄摘要:

Financial Performance:

財務業績:

  • Molina Healthcare reported Q1 2024 adjusted earnings per share of $5.73 on $9.5 billion of premium revenue.

  • The company registered an 88.5% consolidated Medical Care Ratio (MCR), denoting competent medical cost management in all business segments.

  • Despite earnings guidance reporting a $0.30 component, the overall strength of the underlying business counterbalanced it.

  • Molina Healthcare's Q1 MCR for Medicaid was 89.7%, Medicare was at 88.7% and Marketplace stood at 73.3%.

  • Molina has reaffirmed its full-year 2024 guidance of $38 billion of premium revenue and a minimum of $23.50 in earnings per share.

  • Molina Healthcare報告稱,2024年第一季度調整後的每股收益爲5.73美元,保費收入爲95億美元。

  • 該公司的合併醫療保健比率(MCR)爲88.5%,這意味着所有業務領域都有良好的醫療成本管理。

  • 儘管收益指引報告了0.30美元的組成部分,但基礎業務的整體實力抵消了這一點。

  • 莫利納醫療第一季度醫療補助的MCR爲89.7%,醫療保險爲88.7%,Marketplace爲73.3%。

  • 莫利納重申了其2024年全年保費收入380億美元的預期,每股收益至少爲23.50美元。

Business Progress:

業務進展:

  • Over half a million members were added through expansion in California and a new health plan in Nebraska.

  • The company won a substantial RFP contract in Texas, retained a contract in Michigan, and has a robust growth pipeline with imminent opportunities in Kansas, Georgia, and North Carolina.

  • Application of mergers and acquisitions is viewed as a key growth strategy, manifested in the acquisition of Bright HealthCare.

  • Molina projects its Medicaid footprint to be a significant growth catalyst for dual-eligible membership following future CMS directives.

  • The company aims to yield a High Single Digit pre-tax margin by year-end, maintaining a target MCR range of 78% to 80% for the year.

  • Molina expects its Dual-eligible Special Needs Plan (D-SNP) business to be a major growth category.

  • The company anticipates significant growth by 2026 due to a combination of contract wins, M&A, and organic growth.

  • 通過加利福尼亞州的擴張和內布拉斯加州的新健康計劃,增加了超過50萬名會員。

  • 該公司在德克薩斯州贏得了一份大量的RFP合同,在密歇根州保留了一份合同,並且在堪薩斯州、喬治亞州和北卡羅來納州擁有強勁的增長渠道,機會迫在眉睫。

  • 併購的應用被視爲一項關鍵的增長戰略,對光明醫療的收購就體現了這一點。

  • 根據未來的CMS指令,莫利納預計,其醫療補助足跡將成爲雙重資格成員的重要增長催化劑。

  • 該公司的目標是到年底實現較高的個位數稅前利潤率,將該年度的目標MCR區間維持在78%至80%。

  • 莫利納預計,其雙重資格特殊需求計劃(D-SNP)業務將成爲主要的增長類別。

  • 該公司預計,由於合同中標、併購和有機增長相結合,到2026年將實現顯著增長。

More details: Molina Healthcare IR

更多詳情: 莫利納醫療保健 IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論